China / National Reimbursement Drug List (NRDL) 2020: What Reward for Innovation?
Eric Bouteiller examines the most recent update to China’s National Reimbursement Drug List, the positive impact…
innovation
Europe / Can The Beating Cancer Plan Make it an Innovation Leader?
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in Europe, and its potential to boost the continent’s push to catch up with the…
Europe / Will New Pharmaceutical Strategy Prove to be a Game-Changer?
On 25 November 2020, the European Commission adopted a Pharmaceutical Strategy for Europe with the stated aim of…
USA / Is Its Innovation Leadership Position At-Risk?
David H. Crean, managing director for Objective Capital Partners, provides insights on US innovation and long term…
In Conversation
Henrik Asmussen – General Manager, Amgen Switzerland
In a wide-ranging interview, Henrik Asmussen outlines his priorities for Amgen’s important Swiss affiliate, market access and pricing challenges, the company’s exciting pipeline, and what makes Amgen Switzerland a great place to work. I was told when I came that Switzerland is a safe haven with easy access. What I experienced was something entirely different Can you begin by…
USA / Pharma Innovation Factsheet 2020
In a recent article for PharmaBoardroom, Objective Capital’s David Crean took a look at the state of US…
Related Report
USA / Is Its Innovation Leadership Position At-Risk?
David H. Crean, managing director for Objective Capital Partners, provides insights on US innovation and long term…
A New Era of Patient-Led Innovation
Patient groups oftentimes serve as the authority on a specific disease when it comes to advancing research.…
Korea: Prioritising AI in Healthcare Innovation
The South Korean government has designated the promotion of artificial intelligence (AI)-based drug development and…
Pharma Faces / Nares Damrongchai, TCELS, Thailand
Nares Damrongchai has been the CEO of the Thailand Center of Excellence for Life Science (TCELS) since its…
Company Spotlight / JLABS @ Shanghai
Johnson & Johnson’s network of healthcare innovation incubators, JLABS, opened its doors in Shanghai in June…
Latvia / Striving to Catch Up to its Neighbours on Innovation Access
Dr Valters Bolevics, director general of the Association of International Research-based Pharmaceuticals…
Early Access / The UAE as an Initial Product Launch Platform
The UAE’s distinctive willingness to embrace innovation and the ‘can-do’ spirit of authorities marks the…
Turkey Turns Towards Pharmaceutical Innovation
In the coming years, Turkey plans to prioritize R&D initiatives, health studies and medical innovation:…
Merck KGaA / Big-Ticket Investments in Manufacturing Scale & Digital Innovation
Merck KGaA has moved to continuously expand its manufacturing capacity and capability in recent years with a number…
Stockholm: A Hidden Jewel of Life Sciences Innovation in Europe
Some of the key stakeholders in Swedish healthcare and life sciences outline why they feel Sweden’s capital,…
IP in China: From Imitation to Innovation
The Greater Bay Area’s – and in particular, Shenzhen’s – prowess in life sciences manufacturing…
China / Bringing Together Innovation & Investment in Suzhou: CBIIC 2019
On 21 September 2019, the China Pharmaceutical International Innovation and Research Development Association…
The Netherlands: A Fertile Garden for Innovation
Despite lacking a national champion to bolster its innovative eco-system since the 2007 acquisition of Organon by…
Austria: Orchestrating Innovation
Austria has long been merely a cog in the wheel of global R&D, lying in the shadows of neighboring research…
European Cancer Forum 2020 / Belgian MoH Maggie De Block Delivers Strong Message on Access to Innovation
The second edition of the European Cancer Forum was held in Brussels, Belgium on Tuesday, 29 January 2020. Hosted…
China / Boehringer Ingelheim Creates New External Innovation Hub
With its brand new hub in Shanghai dedicated to research, business development and venture funding, German pharma…
China’s Greater Bay Area: Spearheading Innovation
Guangdong province and neighbouring Hong Kong have long been fundamental to China’s metamorphosis into an…
Pathways to Financing Innovation in Hungary
Hungary operates under a state-owned universal National Health Insurance Fund (OEP), completely financed through…
China / National Reimbursement Drug List (NRDL) 2020: What Reward for Innovation?
Eric Bouteiller examines the most recent update to China’s National Reimbursement Drug List, the positive impact…
Speeding Up Access to Innovation in Portugal
A new regulation is helping Portugal’s market access conditions for pharmaceuticals catch up with those of other…
Regulatory Science Struggling to Keep Pace with Innovation
While drug developers, healthcare practitioners and patients all rejoice at the advent of a golden age of…
Portuguese generics: headroom for innovation?
In PharmaBoardroom’s first coverage of Portugal in 2007, generics represented 16 percent of the country’s…
Alzheimer's / Canadian-Led Innovation Post-Aducanumab
Dr Neil Cashman looks at the potential impact of US FDA approval for Biogen’s aducanumab on the search for…
Kobe: A Center of Excellence for Biomedical Innovation
Kenichi Tamiya, director for Biomedical Policy at the Kobe City Government and managing director of the Kobe…
AI / Bridging the Innovation Gap
Professor Jackie Hunter looks at why the pharmaceutical industry has been so slow to adopt artificial…
The future of innovation in Ireland
“If you look at the cuts in the public sector, the science budget has been relatively lightly touched. This sends…
Bridging Data Access Gaps to Drive Innovation in Biopharma
Tom Achoki of Mass Sciences explores the possibilities that better access to high-quality real-world data will…
Download / New UAE Pharma Report April 2020 Out Now
PharmaBoardroom’s latest country report gives an up-to-date and comprehensive overview of one of the most…
USA / Is Its Innovation Leadership Position At-Risk?
David H. Crean, managing director for Objective Capital Partners, provides insights on US innovation and long term…